Cancer-related Cognitive Dysfunction, Cytomegaloviral Infection, Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma
Conditions
Brief summary
This study evaluates the feasibility and accuracy of using saliva to remotely monitor cytomegalovirus (CMV) infection in individuals receiving treatment for ovarian cancer.
Interventions
OTHERNon-Interventional Study
Non-Interventional Study
Sponsors
National Cancer Institute (NCI)
Mayo Clinic
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age ≥ 18 * Ability to read and write in English * Diagnosed with ovarian cancer (ovarian, primary peritoneal, fallopian tube) * Receiving care from providers at Mayo Clinic * Regardless of diseases status, actively receiving treatment for ovarian cancer (frontline, maintenance, progression, recurrence)
Exclusion criteria
* Pregnant at the time of study participation * Inability to provide informed written consent * History of dementia, stroke, brain tumors or other condition which may impair cognitive functioning
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Using saliva and blood samples to remotely monitor cytomegalovirus (CMV) infection | Baseline | Assessed through collection and comparison of blood and saliva samples collected from individuals receiving treatment for ovarian cancer. Samples may be collected in clinic or at home following study enrollment. Saliva will be self-collected using Oragene OGR-600 kits. Blood samples will be collected at the time of another scheduled clinic blood draw (Aim 1) or at home through a home phlebotomy service (Aim 2). |
Countries
United States
Outcome results
None listed